P-ISSN 2575-3819
E-ISSN 2575-3827
Vol. 21, Issue 2, 2014January 01, 2014 EDT
Novartis Ag v. Union of India: “Evergreening,” Trips, and “Enhanced Efficacy” Under Section 3(d)
Novartis Ag v. Union of India: “Evergreening,” Trips, and “Enhanced Efficacy” Under Section 3(d)
Dorothy Du,
Novartis AG v. Union of Indiapharmaceutical industrysecondary patentsIndian Patent ActsevergreeningTrade-Related Aspects of Intellectual Property RightsTRIPSWorld Trade OrganizationIntellectual Property Appellate Boardimatinib mesylateinventive stepnoveltyenhanced efficacydoctrine of inherent anticipationdouble patentingprior art
Dorothy Du, Novartis Ag v. Union of India: “Evergreening,” Trips, and “Enhanced Efficacy” Under Section 3(d), 21 Journal of Intellectual Property 223 (2014).